Ghent University Academic Bibliography

Advanced

Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma

AM Abulayha, SA Tabal, EI Shawesh, MA Elbasir, AS Elbanani, YM Lamami and Amin Bredan UGent (2010) LEUKEMIA RESEARCH. 34(3). p.307-311
abstract
The monoclonal antibody Rituximab is useful for treatment of patients with B-cell non-Hodgkin’s lymphoma. We phenotypically analyzed reconstitution of peripheral B cells in a male patient with follicular lymphoma following their depletion with Rituximab. CD19+ and CD20+ B cell counts in peripheral blood decreased rapidly following Rituximab treatment. Six months after the end of treatment, a few CD19+ B cells were detected in peripheral blood. These cells had a naive B cell phenotype (IgD+, CD27−) and they expressed high levels of CD38 and CD24, which show that the B cell pool was repopulated mainly with immature, naive B cells.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
RHEUMATOID-ARTHRITIS, ANTI-CD20 ANTIBODIES, SURFACE ANTIGEN, LOW-GRADE, THERAPY, CD20, MONOCLONAL-ANTIBODY, NON-HODGKINS-LYMPHOMA, SYSTEMIC-LUPUS-ERYTHEMATOSUS, LYMPHOCYTES
journal title
LEUKEMIA RESEARCH
Leuk. Res.
volume
34
issue
3
pages
5 pages
publisher
PERGAMON-ELSEVIER SCIENCE LTD
place of publication
OXFORD
Web of Science type
Article
Web of Science id
000274529600009
JCR category
ONCOLOGY
JCR impact factor
2.555 (2010)
JCR rank
87/181 (2010)
JCR quartile
2 (2010)
ISSN
0145-2126
DOI
10.1016/j.leukres.2009.06.005
language
English
UGent publication?
yes
classification
A1
copyright statement
I don't know the status of the copyright for this publication
id
902274
handle
http://hdl.handle.net/1854/LU-902274
date created
2010-03-12 10:05:59
date last changed
2012-06-26 14:31:59
@article{902274,
  abstract     = {The monoclonal antibody Rituximab is useful for treatment of patients with B-cell non-Hodgkin{\textquoteright}s lymphoma. We phenotypically analyzed reconstitution of peripheral B cells in a male patient with follicular lymphoma following their depletion with Rituximab. CD19+ and CD20+ B cell counts in peripheral blood decreased rapidly following Rituximab treatment. Six months after the end of treatment, a few CD19+ B cells were detected in peripheral blood. These cells had a naive B cell phenotype (IgD+, CD27\ensuremath{-}) and they expressed high levels of CD38 and CD24, which show that the B cell pool was repopulated mainly with immature, naive B cells.},
  author       = {Abulayha, AM and Tabal, SA and Shawesh, EI and Elbasir, MA and Elbanani, AS and Lamami, YM and Bredan, Amin},
  issn         = {0145-2126},
  journal      = {LEUKEMIA RESEARCH},
  keyword      = {RHEUMATOID-ARTHRITIS,ANTI-CD20 ANTIBODIES,SURFACE ANTIGEN,LOW-GRADE,THERAPY,CD20,MONOCLONAL-ANTIBODY,NON-HODGKINS-LYMPHOMA,SYSTEMIC-LUPUS-ERYTHEMATOSUS,LYMPHOCYTES},
  language     = {eng},
  number       = {3},
  pages        = {307--311},
  publisher    = {PERGAMON-ELSEVIER SCIENCE LTD},
  title        = {Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma},
  url          = {http://dx.doi.org/10.1016/j.leukres.2009.06.005},
  volume       = {34},
  year         = {2010},
}

Chicago
Abulayha, AM, SA Tabal, EI Shawesh, MA Elbasir, AS Elbanani, YM Lamami, and Amin Bredan. 2010. “Depletion of Peripheral Blood B Cells with Rituximab and Phenotype Characterization of the Recovering Population in a Patient with Follicular Lymphoma.” Leukemia Research 34 (3): 307–311.
APA
Abulayha, A., Tabal, S., Shawesh, E., Elbasir, M., Elbanani, A., Lamami, Y., & Bredan, A. (2010). Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma. LEUKEMIA RESEARCH, 34(3), 307–311.
Vancouver
1.
Abulayha A, Tabal S, Shawesh E, Elbasir M, Elbanani A, Lamami Y, et al. Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma. LEUKEMIA RESEARCH. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD; 2010;34(3):307–11.
MLA
Abulayha, AM, SA Tabal, EI Shawesh, et al. “Depletion of Peripheral Blood B Cells with Rituximab and Phenotype Characterization of the Recovering Population in a Patient with Follicular Lymphoma.” LEUKEMIA RESEARCH 34.3 (2010): 307–311. Print.